Nifurtimox is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Not commercially available in the U.S.
    • Available from the CDC under investigational protocols. Drug can be obtained by callingParasitic Diseases Public Inquiries (404-718-4745; e-mail chagas@cdc.gov). Outside of regular business hours call the CDC Emergency Operations Center (770-488-7100) and ask for the person on call for parasitic diseases.

NON-FDA APPROVED USES

  • American trypanosomiasis (Chagas’ disease, T. cruzi): acute early phase of the disease.
  • May be used in combination with eflornithine for the treatment of second-stage sleeping sickness.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: June 7, 2017

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Nifurtimox ID - 540385 A1 - Avdic,Edina,Pharm.D. AU - Pham,Paul,Pharm.D. Y1 - 2017/06/07/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540385/all/Nifurtimox PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -